ReActiv8 is an implantable neurostimulation device that is intended to treat people with chronic low back pain.
The new trial sites are starting to enroll subjects. The clinical trial of ReActiv8 started in March 2014, and the original trial sites in Australia and Belgium continue to enroll subjects.
More Articles on Devices:
35 spine, orthopedic devices receive FDA 510(k) clearance in June
DJO Global Net Sales Up 6.5% in 2Q
Aurora Spine Announces 1st U.S. Surgery Using ZIP Graft Bone Dowel
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
